125 related articles for article (PubMed ID: 19619499)
1. p38MAPK controls expression of multiple cell cycle inhibitors and islet proliferation with advancing age.
Wong ES; Le Guezennec X; Demidov ON; Marshall NT; Wang ST; Krishnamurthy J; Sharpless NE; Dunn NR; Bulavin DV
Dev Cell; 2009 Jul; 17(1):142-9. PubMed ID: 19619499
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of the wip1 gene abrogates the p38 MAPK/p53/Wip1 pathway and silences p16 expression in human breast cancers.
Yu E; Ahn YS; Jang SJ; Kim MJ; Yoon HS; Gong G; Choi J
Breast Cancer Res Treat; 2007 Mar; 101(3):269-78. PubMed ID: 16897432
[TBL] [Abstract][Full Text] [Related]
3. Regulation of ATM/p53-dependent suppression of myc-induced lymphomas by Wip1 phosphatase.
Shreeram S; Hee WK; Demidov ON; Kek C; Yamaguchi H; Fornace AJ; Anderson CW; Appella E; Bulavin DV
J Exp Med; 2006 Dec; 203(13):2793-9. PubMed ID: 17158963
[TBL] [Abstract][Full Text] [Related]
4. Wip1-dependent signaling pathways in health and diseases.
Zhu YH; Bulavin DV
Prog Mol Biol Transl Sci; 2012; 106():307-25. PubMed ID: 22340722
[TBL] [Abstract][Full Text] [Related]
5. PP2Cdelta (Ppm1d, WIP1), an endogenous inhibitor of p38 MAPK, is regulated along with Trp53 and Cdkn2a following p38 MAPK inhibition during mouse preimplantation development.
Hickson JA; Fong B; Watson PH; Watson AJ
Mol Reprod Dev; 2007 Jul; 74(7):821-34. PubMed ID: 17219434
[TBL] [Abstract][Full Text] [Related]
6. p16INK4a induces an age-dependent decline in islet regenerative potential.
Krishnamurthy J; Ramsey MR; Ligon KL; Torrice C; Koh A; Bonner-Weir S; Sharpless NE
Nature; 2006 Sep; 443(7110):453-7. PubMed ID: 16957737
[TBL] [Abstract][Full Text] [Related]
7. WIP1 phosphatase at the crossroads of cancer and aging.
Le Guezennec X; Bulavin DV
Trends Biochem Sci; 2010 Feb; 35(2):109-14. PubMed ID: 19879149
[TBL] [Abstract][Full Text] [Related]
8. Mitogen-activated protein kinases and protein phosphatase 5 mediate glucocorticoid-induced cytotoxicity in pancreatic islets and β-cells.
Fransson L; Rosengren V; Saha TK; Grankvist N; Islam T; Honkanen RE; Sjöholm Å; Ortsäter H
Mol Cell Endocrinol; 2014 Mar; 383(1-2):126-36. PubMed ID: 24361515
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of Wip1 overexpression and its association with the p38MAPK/p53/p16 pathway in NSCLC.
Yang S; Dong S; Qu X; Zhong X; Zhang Q
Mol Med Rep; 2017 Feb; 15(2):719-723. PubMed ID: 27959454
[TBL] [Abstract][Full Text] [Related]
10. The estrogen receptor alpha pathway induces oncogenic Wip1 phosphatase gene expression.
Han HS; Yu E; Song JY; Park JY; Jang SJ; Choi J
Mol Cancer Res; 2009 May; 7(5):713-23. PubMed ID: 19435816
[TBL] [Abstract][Full Text] [Related]
11. Cellular repressor E1A-stimulated genes controls phenotypic switching of adventitial fibroblasts by blocking p38MAPK activation.
Li Y; Tao J; Zhang J; Tian X; Liu S; Sun M; Zhang X; Yan C; Han Y
Atherosclerosis; 2012 Dec; 225(2):304-14. PubMed ID: 23040447
[TBL] [Abstract][Full Text] [Related]
12. Adaptor protein Crk induces Src-dependent activation of p38 MAPK in regulation of synovial sarcoma cell proliferation.
Watanabe T; Tsuda M; Tanaka S; Ohba Y; Kawaguchi H; Majima T; Sawa H; Minami A
Mol Cancer Res; 2009 Sep; 7(9):1582-92. PubMed ID: 19737974
[TBL] [Abstract][Full Text] [Related]
13. Inactivation of the Wip1 phosphatase inhibits mammary tumorigenesis through p38 MAPK-mediated activation of the p16(Ink4a)-p19(Arf) pathway.
Bulavin DV; Phillips C; Nannenga B; Timofeev O; Donehower LA; Anderson CW; Appella E; Fornace AJ
Nat Genet; 2004 Apr; 36(4):343-50. PubMed ID: 14991053
[TBL] [Abstract][Full Text] [Related]
14. The role of the MKK6/p38 MAPK pathway in Wip1-dependent regulation of ErbB2-driven mammary gland tumorigenesis.
Demidov ON; Kek C; Shreeram S; Timofeev O; Fornace AJ; Appella E; Bulavin DV
Oncogene; 2007 Apr; 26(17):2502-6. PubMed ID: 17016428
[TBL] [Abstract][Full Text] [Related]
15. Wip1 phosphatase positively modulates dendritic spine morphology and memory processes through the p38MAPK signaling pathway.
Fernandez F; Soon I; Li Z; Kuan TC; Min DH; Wong ES; Demidov ON; Paterson MC; Dawe G; Bulavin DV; Xiao ZC
Cell Adh Migr; 2012; 6(4):333-43. PubMed ID: 22983193
[TBL] [Abstract][Full Text] [Related]
16. Mice deficient for the wild-type p53-induced phosphatase gene (Wip1) exhibit defects in reproductive organs, immune function, and cell cycle control.
Choi J; Nannenga B; Demidov ON; Bulavin DV; Cooney A; Brayton C; Zhang Y; Mbawuike IN; Bradley A; Appella E; Donehower LA
Mol Cell Biol; 2002 Feb; 22(4):1094-105. PubMed ID: 11809801
[TBL] [Abstract][Full Text] [Related]
17. Senescent growth arrest in mesenchymal stem cells is bypassed by Wip1-mediated downregulation of intrinsic stress signaling pathways.
Lee JS; Lee MO; Moon BH; Shim SH; Fornace AJ; Cha HJ
Stem Cells; 2009 Aug; 27(8):1963-75. PubMed ID: 19544416
[TBL] [Abstract][Full Text] [Related]
18. Dipyridamole activation of mitogen-activated protein kinase phosphatase-1 mediates inhibition of lipopolysaccharide-induced cyclooxygenase-2 expression in RAW 264.7 cells.
Chen TH; Kao YC; Chen BC; Chen CH; Chan P; Lee HM
Eur J Pharmacol; 2006 Jul; 541(3):138-46. PubMed ID: 16765938
[TBL] [Abstract][Full Text] [Related]
19. The Wip1 phosphatase PPM1D dephosphorylates SQ/TQ motifs in checkpoint substrates phosphorylated by PI3K-like kinases.
Yamaguchi H; Durell SR; Chatterjee DK; Anderson CW; Appella E
Biochemistry; 2007 Nov; 46(44):12594-603. PubMed ID: 17939684
[TBL] [Abstract][Full Text] [Related]
20. Involvement of p38 mitogen-activated protein kinase in the cell growth inhibition by sodium arsenite.
Kim JY; Choi JA; Kim TH; Yoo YD; Kim JI; Lee YJ; Yoo SY; Cho CK; Lee YS; Lee SJ
J Cell Physiol; 2002 Jan; 190(1):29-37. PubMed ID: 11807808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
